Abstract
The existent investigation deals with synthesis, characterization, computational analysis, and biological activities of some hydroxytriazene derivatives containing sulphonamide moiety. The compounds were screened for antidiabetic, antioxidant, and anti-inflammatory activities. The antidiabetic activity was assessed using α-glucosidase and α-amylase inhibition assays with IC50 values ranging from 32.0 to 759.13 μg/mL and 157.77 to 340.47 μg/mL while standard drug acarbose showed IC50 values 12.21 and 69.74 μg/mL, respectively. The antioxidant activity was evaluated using DPPH and ABTS radical scavenging assays with IC50 value ranging from 54.01 to 912.66 μg/mL and 33.22 to 128.11 μg/mL, and standard drug ascorbic acid showed IC50 values 29.12 μg/mL and 69.13 μg/mL, respectively. Anti-inflammatory activity was investigated using the carrageenan-induced paw edema method, where percentage inhibition was up to 93.0 and 98.57 for 2 h and 4 h, respectively, and all the compounds were found to exhibit excellent anti-inflammatory activity. Moreover, prediction of activity spectra for substance and molecular docking were also performed. The PASS prediction hypothesized the potential of the compounds for anti-inflammatory activity, and docking results suggested the best binding pose for compounds 1b and 2b with the least energy value from which compounds can be considered as potent COX-2 inhibitors. Furthermore, possible interactions between hydroxytriazene analogues and the targets of antioxidant NADPH oxidase and antidiabetic human maltase-glucoamylase enzyme have been identified. The HOMO and LUMO analysis revealed charge transfer within the compounds. These findings suggested that the synthesized compounds can be potential agents for the treatment of diabetes and inflammation.
Graphical abstract
Similar content being viewed by others
Data availability
Materials and methods and all the instrumentation spectra like IR, 1H NMR, 13C NMR, and mass spectra are provided in the SI.
References
Mukherjee N, Lin L, Contreras CJ, Templin AT (2021) Β-cell death in diabetes: past discoveries, present understanding, and potential future advances. Metabolites 11:796
Esser N, Utzschneider KM, Kahn SE (2020) Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia 63:2007–2021
Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF (2020) Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 8:1–1
Min SH, Yoon JH, Hahn S, Cho YM (2018) Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: a systematic review with meta-analysis. J Diabetes Investig 9:893–902
Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, Wang W, Zhou X, Zhang M, Sun X (2016) Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis. Sci Rep 6:1–8
Dahlen A, Dashi G, Maslov I, Attwood MM, Jonsson J, Trukhan V, Schiöth HB (2022) Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales. Front Pharmacol 19:807548
Zhang L, Wang X, Cueto R, Effi C, Zhang Y, Tan H, Qin X, Ji Y, Yang X, Wang H (2019) Biochemical basis and metabolic interplay of redox regulation. Redox Biol 26:101284. https://doi.org/10.1016/j.redox.2019.101284
Sharma GN, Gupta G, Sharma P (2018) A comprehensive review of free radicals, antioxidants, and their relationship with human ailments. Crit Rev Eukaryot Gene Expr 28:139–154
Karam HM, Radwan RR (2019) Metformin modulates cardiac endothelial dysfunction, oxidative stress and inflammation in irradiated rats: A new perspective of an antidiabetic drug. Clin Exp Pharmacol Physiol 46:1124–1132. https://doi.org/10.1111/1440-1681.13148
Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 16:27–41
Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737. https://doi.org/10.1038/nri3073
Li D, Wu M (2021) Pattern recognition receptors in health and diseases. Sig Transduct Target Ther 6:291
Tourki B, Halade GV (2021) Heart failure syndrome with preserved ejection fraction is a metabolic cluster of non-resolving inflammation in obesity. Front Cardiovasc Med 8:695952
Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428–435. https://doi.org/10.1038/nature07201
Geronikaki AA, Lagunin AA, Hadjipavlou-Litina DI, Eleftheriou PT, Filimonov DA, Poroikov VV, Alam I, Saxena AK (2008) Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. J Med Chem 51:1601–1609. https://doi.org/10.1021/jm701496h
Amatruda JG, Katz R, Peralta CA, Estrella MM, Sarathy H, Fried LF, Newman AB, Parikh CR, Ix JH, Sarnak MJ, Shlipak MG (2021) Association of non-steroidal anti-inflammatory drugs with kidney health in ambulatory older adults. J Am Geriatrics Soc 69:726–34
Akgul O, Mannelli CDL, Vullo D, Angeli A, Ghelardini C, Bartolucci G, Altamimi ASA, Scozzafava A, Supuran TC, Carta F (2018) Discovery of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs–CAIs) for the management of rheumatoid. J Med Chem 61:4961–4977. https://doi.org/10.1021/acs.jmedchem.8b00420
Apaydın S, Torok M (2019) Sulfonamide derivatives as multi-target agents for complex diseases. Bioorg Med Chem Lett 15:2042–2050
Zhang J, Tan Y, Li G, Chen L, Nie M, Wang Z, Ji H (2021) Coumarin sulfonamides and amides derivatives: design, synthesis, and antitumor activity in vitro. Molecules 26:786
Badgujar JR, More DH, Meshram JS (2018) Synthesis, antimicrobial and antioxidant activity of pyrazole based sulfonamide derivatives. Indian J Microbiol 58:93–99. https://doi.org/10.1007/s12088-017-0689-6
Shafique M, Hameed S, Naseer MM, Al-Masoudi NA (2018) Synthesis of new chiral 1,3,4-thiadiazole-based di- and tri-arylsulfonamide residues and evaluation of in vitro anti-HIV activity and cytotoxicity. Mol Divers 22:957–968. https://doi.org/10.1007/s11030-018-9851-2
Berredjem M, Bouzina A, Bahadi R, Bouacida S, Rastija V, Djouad SE, Sothea TO, Almalki FA, Hadda TB, Aissaoui M (2022) Antitumor activity, X-Ray crystallography, in silico study of some-sulfamido-phosphonates. Identification of pharmacophore sites. J Mol Struc 1250:131886
Demir Y, Koksal Z (2020) Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes. Arch Physiol Biochem 23:1–6. https://doi.org/10.1080/13813455.2020.1742166
Poudapally S, Battu S, Velatooru LR, Bethu MS, Rao JV, Sharma S, Sen S, Pottabathini N, Iska VBR, Katangoor V (2017) Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents. Bioorg Med Chem Lett 27:1923–1928. https://doi.org/10.1016/j.bmcl.2017.03.042
Pervaiz M, Riaz A, Munir A, Saeed Z, Hussain S, Rashid A, Younas U, Adnan A (2020) Synthesis and characterization of sulfonamide metal complexes as antimicrobial agents. J Mol Struct 1202:127284. https://doi.org/10.1016/j.molstruc.2019.127284
Irfan A, Ahmad S, Hussain S, Batool F, Riaz H, Zafar R, Kotwica-Mojzych K, Mojzych M (2021) Recent updates on the synthesis of bioactive quinoxaline-containing sulfonamides. Appl Sci 11:5702. https://doi.org/10.3390/app11125702
Ovung A, Bhattacharyya J (2021) Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys Rev 13:259–272. https://doi.org/10.1007/s12551-021-00795-9
Taha M, Imran S, Salahuddin M, Iqbal N, Rahim F, Uddin N, Shehzad A, Farooq RK, Alomari M, Khan KM (2021) Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin induced diabetic albino wistar rats. Bioorg Chem 110:104808. https://doi.org/10.1016/j.bioorg.2021.104808
Alyar S, Şen T, Ozdemir UO, Alyar H, Adem S, Şen C (2019) Synthesis, spectroscopic characterizations, enzyme inhibition, molecular docking study and DFT calculations of new Schiff bases of sulfa drugs. J Mol Struc 1185:416–424. https://doi.org/10.1016/j.molstruc.2019.03.002
Mendes CP, Postal BG, Oliveira GT, Castro AJ, Frederico MJ, Moraes AL, Neuenfeldt PD, Nunes RJ, Menegaz D, Silva FR (2019) Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets. J Cell Physiol 234:509–520
Purohit DN (1967) Hydroxytriazenes-a review of a new class of chelating agents. Talanta 14:353–359. https://doi.org/10.1016/0039-9140(67)80009-2
Purohit DN, Tyagi MP, Bhatnagar R, Bishnoi IR (1992) Hydroxytriazenes as chelating agents: a review. Revs Anal Chem 11:269–303. https://doi.org/10.1515/REVAC.1992.11.3-4.269
Kumar S, Garg M, Jodha JS, Singh RP, Pareek N, Chauhan RS, Goswami AK (2009) Studies on insecticidal activity of some hydroxytriazenes derivatives. E-J Chem 6:466–468. https://doi.org/10.1155/2009/943576
Ombaka AO, Muguna AT, Gichumbi JM (2012) Antibacterial and antifungal activities of novel hydroxytriazenes. J Environ Chem Ecotoxicol 4:133–136. https://doi.org/10.5897/JECE12.006
Jain S, Dayma V, Sharma P, Bhargava A, Baroliya PK, Goswami AK (2019) Synthesis of some new hydroxytriazenes and their antimicrobial and anti-inflammatory activities. Anti-Inflamm Anti-Allergy Agents Med Chem 19:50–60. https://doi.org/10.2174/1871523018666190301151826
Regar M, Baroliya PK, Patidar A, Dashora R, Mehta A, Chauhan RS, Goswami AK (2016) Antidyslipidemic and antioxidant effects of novel hydroxytriazenes. Pharm Chem J 50:310–314. https://doi.org/10.1007/s11094-016-1442-x
Goswami AK, Ameta KL, Khan S (2020) Hydroxytriazenes and triazenes: the versatile framework and medicinal applications, 1st edn. CRC Press, Boca Raton
Singh K, Patel P, Goswami AK (2008) Anti-inflammatory activity of hydroxytriazenes and their Vanadium complexes. E-J Chem 5:1144–1148. https://doi.org/10.1155/2008/830737
Agarwal S, Baroliya PK, Bhargava A, Tripathi IP, Goswami AK (2016) Synthesis, characterization, theoretical prediction of activities and evaluation of biological activities of some sulfacetamide based hydroxytriazenes. Bioorg Med Chem Lett 26:2870–2873. https://doi.org/10.1016/j.bmcl.2016.04.051
Sharma P, Dayma V, Dwivedi A, Baroliya PK, Tripathi IP, Vanangamudi M, Chauhan RS, Goswami AK (2020) Synthesis of sulpha drug-based hydroxytriazene derivatives: anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies. Biorg Chem 96:103642. https://doi.org/10.1016/j.bioorg.2020.103642
Dayma V, Chopra J, Sharma P, Dwivedi A, Tripathi IP, Bhargava A, Murugesan V, Goswami AK, Baroliya PK (2020) Synthesis, antidiabetic, antioxidant and anti-inflammatory activities of novel hydroxytriazenes based on sulphadrugs. Heliyon 6:e04787. https://doi.org/10.1016/j.heliyon.2020.e04787
Hasaninezhad F, Tavaf Z, Panahi F, Nourisefat M, Khalafi-Nezhad A, Yousefi R (2020) The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes. J Diabetes Metab Disord 19:1505–1515. https://doi.org/10.1007/s40200-020-00685-z
Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y (2020) Oxidative stress and diabetes: antioxidative strategies. Front Med 14:583–600. https://doi.org/10.1007/s11684-019-0729-1
Ceriello A, Testa R, Genovese S (2016) Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutr Metab Cardiovasc Dis 26:285–292. https://doi.org/10.1016/j.numecd.2016.01.006
Balbi ME, Tonin FS, Mendes AM, Borba HH, Wiens A, Llimos FF, Pontarolo R (2018) Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr 10:1–12. https://doi.org/10.1186/s13098-018-0318-5
Oguntibeju OO (2019) Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 11:45–63
Ng CY, Kamisah Y, Faizah O, Jaarin K (2012) The role of repeatedly heated soybean oil in the development of hypertension in rats: association with vascular inflammation. Int J Exp Pathol 93:377–387. https://doi.org/10.1111/j.1365-2613.2012.00839.x
Pacurari M, Kafoury R, Tchounwou BP, Ndebele K (2014) The Renin-angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflamm 2014:1–13. https://doi.org/10.1155/2014/689360
Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, KiyoharaY OH, Kaikita K, Oike Y (2014) Role of endothelial cell-derived Angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 34:790–800. https://doi.org/10.1161/ATVBAHA.113.303116
Ito F, Sono Y, Ito T (2019) Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants 8:72
De Lavor EM, Fernandes AW, de Andrade Teles RB, Leal AE, de Oliveira Júnior RG, Gama e Silva M, De Oliveira AP, Silva JC, de Moura Fontes Araujo MT, Coutinho HD, De Menezes IR (2018) Essential oils and their major compounds in the treatment of chronic inflammation: a review of antioxidant potential in preclinical studies and molecular mechanisms. Oxid Med Cell Longev 23:6468593
Geronikaki A, Lagunin A, Poroikov V, Filimonov D, Hadjipavlou-litina D, Vicini P (2002) Computer aided prediction of biological activity spectra: Evaluating versus known and predicting of new activities for thiazole derivatives. SAR QSAR Environ Res 13:457–471. https://doi.org/10.1080/10629360290014322
Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, Poroikov VV (2014) Prediction of the biological activity spectra of organic compounds using the PASS online web resources. Chem Heterocycl Compd 50:444–457. https://doi.org/10.1007/s10593-014-1496-1
Wang JL, Limburg D, Granato MJ, Springer J, Joseph HRB, Liao S, Pawlitz JL, Kurumbail RG, Maziasz T, Talley JJ, Kiefer JR, Carter J (2010) The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg Med Chem Lett 20:7159–7163. https://doi.org/10.1016/j.bmcl.2010.07.054
Molecular Operating Environment (MOE) (2016) 2015.10; Chemical Computing Group Inc., 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, https://www.chemcomp.com/index.htm
Galli CL, Sensi C, Fumagalli A, Parravicini C, Marinovich M, Eberini I (2014) A computational approach to evaluate the androgenic affinity of iprodione, procymidone, Vinclozolin and their metabolites. PLoS one 9:e104822. https://doi.org/10.1371/journal.pone.0104822
Tripathi IP, Dwivedi A (2016) Synthesis, characterization and α-glucosidase inhibition of some copper, cobalt, nickel and zinc complexes with N-Methylethylenediamine. Br J Med Med Res 16:1–11. https://doi.org/10.9734/BJMMR/2016/26100
Ilyasov IR, Beloborodov VL, Selivanova IA, Terekhov RP (2020) ABTS/PP decolorization assay of antioxidant capacity reaction pathways. Int J Mol Sci 21:1131. https://doi.org/10.3390/ijms21031131
Re R, Pellegrini N, Proteggente A, Pannala A, Yan M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237. https://doi.org/10.1016/S0891-5849(98)00315-3
Winter CA, Risley EA, Nuss GW (1962) Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Exp Biol Med 111:544–547
Blobaum AL, Marnett LJ (2007) Structural and functional basis of Cyclooxygenase inhibition. J Med Chem 50:1425–1441. https://doi.org/10.1021/jm0613166
Li X, Mazaleuskaya LL, Ballantyne LL, Meng H, FitzGerald GA, Funk CD (2018) Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice1,2[S]. J Lipid Res 59:102–112. https://doi.org/10.1194/jlr.M080028
Simone RD, Chini MG, Bruno I, Riccio R, Mueller D, Werz O, Bifulco G (2011) Structure-based discovery of inhibitors of microsomal prostaglandin E2 Synthase-1,5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents. J Med Chem 54:1565–1575. https://doi.org/10.1021/jm101238d
Khalil NA, Ahmed EM, Mohamed KO, Nissan YM, Zaitone Abo-Bakr S (2014) Synthesis and biological evaluation of new pyrazolone–pyridazine conjugates as anti-inflammatory and analgesic agents. Bioorg Med Chem 22:2080–2089. https://doi.org/10.1016/j.bmc.2014.02.042
Cash JM, Klippel JH (1994) Second-line drug therapy for rheumatoid arthritis. New Eng J Med 330:1368–1375. https://doi.org/10.1056/NEJM199405123301908
Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D, Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R (2007) Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology 132:490–497. https://doi.org/10.1053/j.gastro.2006.11.012
Harirforoosh S, Asghar W, Jamali F (2013) Trial Adverse effects of nonsteroidal anti-inflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharmaceut Sci 16:821–847
Wu KKW, Sung JJY, Lee CW, Yu J, Cho CH (2010) Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 295:7–16. https://doi.org/10.1016/j.canlet.2010.03.015
Noureddine O, Issaoui N, Al-Dossary O (2021) DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19. J King Saud Univ Sci 33:101248
Dehkordi MM, Asgarshamsi MH, Fassihi A, Zborowski KK (2022) A comparative DFT study on the antioxidant activity of some novel 3-hydroxypyridine-4-one derivatives. Chem Biodivers. 8:e202100703
Thompson M A (2004) Arguslab computational chemistry software: a molecular modeling, graphics and drug design program. http://www.arguslab.com
Acknowledgements
Authors are thankful to SAIF, Chandigarh, India and MNIT, Jaipur, India for providing spectral analysis.
Funding
P.K. Baroliya acknowledges the financial support from the Science and Engineering Research Board, Government of India, for the award of the TARE grant (TAR/2018/000282).
Author information
Authors and Affiliations
Contributions
The manuscript was written through the contributions of all authors. All authors have approved to the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that there are no conflicts of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chauhan, L.K., Chopra, J., Vanangamudi, M. et al. Hydroxytriazenes incorporating sulphonamide derivatives: evaluation of antidiabetic, antioxidant, anti-inflammatory activities, and computational study. Mol Divers 27, 223–237 (2023). https://doi.org/10.1007/s11030-022-10420-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-022-10420-w